Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Bouter

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Brain Sciences|June 2, 2021
Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α AutoantibodiesNiels Hansen, Claudia Lange, Fabian Maass, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2015
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinomaCarsten-Oliver Sahlmann, Birgit Meller, Caroline Bouter, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 5, 2022
Brain <sup>18</sup> F-FDG-PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's diseaseKatharina Woyk, Carsten Oliver Sahlmann, Niels Hansen, et al.
Brain Sciences|February 25, 2023
New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy BodiesNiels Hansen, Caroline Bouter, Sebastian Johannes Müller, et al.
Alzheimer'S Research & Therapy|December 12, 2018
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's diseaseHedieh Shahpasand-Kroner, Hans-W Klafki, Chris Bauer, et al.
BMC Neurology|March 25, 2022
Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRIEya Khadhraoui, Sebastian Johannes Müller, Niels Hansen, et al.
Frontiers in Aging Neuroscience|January 24, 2019
<sup>18</sup>F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's DiseaseCaroline Bouter, Philipp Henniges, Timon N Franke, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease miceFrederik W Ott, Marius E Sichler, Caroline Bouter, et al.
Frontiers in Aging Neuroscience|October 24, 2022
Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onsetNiels Hansen, Sebastian Johannes Müller, Eya Khadhraoui, et al.
Scientific Reports|April 1, 2022
Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficitsNadine Curdt, Franziska W Schmitt, Caroline Bouter, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Brain Sciences|June 2, 2021
Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α AutoantibodiesNiels Hansen, Claudia Lange, Fabian Maass, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2015
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinomaCarsten-Oliver Sahlmann, Birgit Meller, Caroline Bouter, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 5, 2022
Brain <sup>18</sup> F-FDG-PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's diseaseKatharina Woyk, Carsten Oliver Sahlmann, Niels Hansen, et al.
Brain Sciences|February 25, 2023
New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy BodiesNiels Hansen, Caroline Bouter, Sebastian Johannes Müller, et al.
Alzheimer'S Research & Therapy|December 12, 2018
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's diseaseHedieh Shahpasand-Kroner, Hans-W Klafki, Chris Bauer, et al.
BMC Neurology|March 25, 2022
Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRIEya Khadhraoui, Sebastian Johannes Müller, Niels Hansen, et al.
Frontiers in Aging Neuroscience|January 24, 2019
<sup>18</sup>F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's DiseaseCaroline Bouter, Philipp Henniges, Timon N Franke, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease miceFrederik W Ott, Marius E Sichler, Caroline Bouter, et al.
Frontiers in Aging Neuroscience|October 24, 2022
Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onsetNiels Hansen, Sebastian Johannes Müller, Eya Khadhraoui, et al.
Scientific Reports|April 1, 2022
Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficitsNadine Curdt, Franziska W Schmitt, Caroline Bouter, et al.
Pageof 4